CAS: 1202055-32-0
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
NMS-P715 REF: TM-T12237CAS: 1202055-32-0 | 98.41% | 78.00 €~920.00 € | Wed 04 Dec 24 | |
NMS P715 REF: 3D-FN104282CAS: 1202055-32-0 | Min. 95% | To inquire | Wed 15 Jan 25 | |
NMS-P715 REF: IN-DA008TMSCAS: 1202055-32-0 | % | - - - | Discontinued product |
NMS-P715
CAS:1202055-32-0
NMS-P715 is a highly selective and ATP-competitive MPS1 inhibitor(IC50 of 182 nM).
Formula:
C35H39F3N8O3
Purity:
98.41%
Color and Shape:
Solid
Molecular weight:
676.73
Ref: TM-T12237
1mg | 78.00 € | ||
2mg | 95.00 € | ||
5mg | 149.00 € | ||
10mg | 230.00 € | ||
25mg | 452.00 € | ||
50mg | 665.00 € | ||
100mg | 920.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
NMS P715
CAS:1202055-32-0
NMS P715 is a cell-cycle inhibitor that specifically inhibits the mitotic checkpoint kinase CDK4/6. NMS …
Formula:
C35H39F3N8O3
Purity:
Min. 95%
Molecular weight:
676.73 g/mol
Ref: 3D-FN104282
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
Ref: IN-DA008TMS
1mg | Discontinued | Request information | |
2mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |